Fact CheckerSign in

NCT06284629Active, not recruiting

Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes.

PD-DigiCare: Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes - a Multicentre Randomized Controlled Trial.

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

The overall aim of the trial is to compare the efficacy of using wearables and patient-reported outcome measures versus standard care in enhancing the timeliness of referrals to advanced monitoring of treatments for people with Parkinson's Disease.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
75 (estimated)
First submitted
14 Feb 2024
Start date
1 Nov 2024
Primary completion date
1 Nov 2026
Lead sponsor
Copenhagen University Hospital, Rigshospitalet
NCT number
NCT06284629

What you commit to

  • Study type: Interventional
  • Planned participants: 75
  • From 1 Nov 2024 to the primary completion date, 1 Nov 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Suffering from severe psychiatric disorders.
  • Otherwise not qualified to receive advanced treatment (e.g., advanced cancer, severe heart failure).

Other

  • Consistent use of a wheelchair or walker which may interfere significantly with the remote monitoring of PD motor symptoms.
  • Lack of understanding and proficiency in the Danish language.
  • Inability to use wearable devices due to non-compliance, physical and/or skin sensitivity.
  • Already undergoing advanced treatment.
  • Diagnosed with atypical or secondary parkinsonism.
  • Other patient groups otherwise deemed ineligible by the project manager.

Who the study is looking for

  • Diagnosed with Idiopathic Parkinson's Disease
  • Taking five or more doses of levodopa daily, or 4 doses levodopa and a COMT-inhibitor
  • Experiencing fluctuations in motor function with regards to OFF time and/or dyskinesia.
  • Able and motivated to utilize a digital product, either alone or assisted by a caregiver.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rigshospitalet Glostrup
Coordinator of this site? Confirm its status
Glostrup MunicipalityDenmarkUnknown status
Odense University Hospital
Coordinator of this site? Confirm its status
OdenseDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.